Who may be affected: Telehealth companies, health care facilities, medical spas, and other entities that have been integral to increasing patient access to GLP-1 agonists through compounding should take heed of the apparent heightened concern FDA is now messaging to the public
Marijuana has no effect, whatsoever, on glaucoma
Zhang Z, Zhang Q, Tan Y, et al
She was warm, professional, and incredibly knowledgeable
The loss of enterohepatic recirculation would definitely cause an additional loss of 5mcg of B12 that is not recovered from bile
Injectable GLP-1 Medications The established injectable options are semaglutide (Ozempic for type 2 diabetes, Wegovy for weight loss) and tirzepatide (Mounjaro for type 2 diabetes, Zepbound for weight loss), both given as once-weekly subcutaneous injections